Abbott Laboratories (ABT) — closed signal from November 4, 2025
Partial Published before the outcome was known, scored automatically when the window closed on February 2, 2026.
Predicted vs. what happened
What happened
Reached 39% of the predicted growth at its peak, without hitting the target.
The thesis — published November 4, 2025
Abbott is a strong, steady healthcare company that seems temporarily beaten down. Signs that the slide is easing suggest a near-term turn upward. Recent legal wins and steady growth in its medical devices pushed experts to raise price goals to about 144. As hospital budgets return to normal and pressure from a strong dollar fades, the stock could move back toward typical levels within 0-3 months, supported by dependable cash flow.
Primary drivers
- Experts raised price targets after legal wins and device growth
- Shares look washed out, hinting at a near-term rebound as selling cools
- Reliable cash flow and trusted brand offer stability in shaky markets
- Recent updates improved sentiment, drawing more investor interest
How it played out
ABT: target was not reached
Lyra published ABT at 124.62 on 2025-11-04, with an entry zone of 123 to 125. The thesis expected 15% growth toward 143.31 over 0-3 months. It pointed to raised price goals after legal wins and device growth, a washed-out share price, reliable cash flow, a trusted brand, and improved sentiment.
Inside the window, ABT peaked at 132.03 on 2025-11-18, up 5.9%. It stayed below the 143.31 target and never reached it. By 2026-02-02, it ended at 109.41. The thesis only partially played out: there was an early rebound, but it faded and missed the target.
What happened during the window
On 2025-11-20, Abbott announced a deal to buy Exact Sciences. On 2026-01-22, Investor's Business Daily reported that Abbott fell after its fourth-quarter update, with sales below forecasts and softer first-quarter guidance.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.